https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-24 / Pharmaceutics 2022 Aug;14(9)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-24 / Pharmaceutics 2022 Aug;14(9)2022-08-24 00:00:002022-08-24 00:00:00Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-21 / Cancers (Basel) 2022 Aug;14(16)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-21 / Cancers (Basel) 2022 Aug;14(16)2022-08-21 00:00:002022-08-21 00:00:00Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-10 / Immunol Invest 2022 Nov;51(8):2133-2158
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-10 / Immunol Invest 2022 Nov;51(8):2133-21582022-08-10 00:00:002022-08-10 00:00:00Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-03 / J Control Release 2022 Sep;349:844-875
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-03 / J Control Release 2022 Sep;349:844-8752022-08-03 00:00:002022-08-03 00:00:00Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-08-01 / Int Immunopharmacol 2022 Sep;110:1090162022-08-01 00:00:002022-08-01 00:00:00Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-25 / Epigenomics 2022 Jul;14(14):865-886
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-25 / Epigenomics 2022 Jul;14(14):865-8862022-07-25 00:00:002022-07-25 00:00:00Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-22 / Front Mol Biosci 2022;9:816510
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-22 / Front Mol Biosci 2022;9:8165102022-07-22 00:00:002023-03-07 13:25:25Glucose Deprivation Induced by Acarbose and Oncolytic Newcastle Disease Virus Promote Metabolic Oxidative Stress and Cell Death in a Breast Cancer Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-3065
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-15 / Clin Cancer Res 2022 Jul;28(14):3053-30652022-07-15 00:00:002022-07-15 00:00:00An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-313
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-14 / Cancer Immunol Immunother 2023 Feb;72(2):301-3132022-07-14 00:00:002022-07-14 00:00:00Personalized tumor vaccine for pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-07-09 / Heliyon 2022 Jul;8(7):e09915
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-07-09 / Heliyon 2022 Jul;8(7):e099152022-07-09 00:00:002022-07-09 00:00:00Comparison between intratumoral and intravenously administered oncolytic virus therapy with Newcastle disease virus in a xenograft murine model for pancreatic adenocarcinoma
